Share Price and Basic Stock Data
Last Updated: March 6, 2026, 3:19 am
| PEG Ratio | -0.59 |
|---|
📊 Last updated
13d ago
Feb 26, 2026
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Uflex Ltd, a leading player in the packaging and containers industry, reported a revenue of ₹15,159 Cr for the trailing twelve months (TTM). The company has shown significant growth in its sales, rising from ₹13,127 Cr in FY 2022 to ₹14,663 Cr in FY 2023. However, the latest fiscal year (FY 2024) witnessed a decline in sales to ₹13,364 Cr, although projections indicate a rebound to ₹15,036 Cr in FY 2025. Quarterly sales trends reflect a recovery, with ₹3,369 Cr recorded in September 2023 and expected to rise to ₹3,833 Cr by September 2024. This fluctuation indicates a possible seasonal impact or market volatility affecting demand. Uflex’s operating profit margin (OPM) stood at 10% for the current fiscal year, which is lower than the industry average, suggesting a need for cost management strategies. The company’s sales per share increased to ₹2,082.23, indicating an upward trajectory in operational efficiency, although it remains essential to monitor the competitive landscape as market dynamics evolve.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Uflex Ltd | 3,291 Cr. | 456 | 686/447 | 13.8 | 1,070 | 0.66 % | 7.75 % | 3.29 % | 10.0 |
| AGI Greenpac Ltd | 3,301 Cr. | 510 | 1,009/500 | 9.76 | 343 | 1.37 % | 19.9 % | 16.2 % | 2.00 |
| Jindal Poly Films Ltd | 3,231 Cr. | 738 | 747/360 | 932 | 0.80 % | 5.36 % | 2.15 % | 10.0 | |
| Polyplex Corporation Ltd | 2,579 Cr. | 821 | 1,398/774 | 85.2 | 1,287 | 1.64 % | 7.16 % | 5.72 % | 10.0 |
| XPRO India Ltd | 2,055 Cr. | 876 | 1,332/842 | 160 | 292 | 0.23 % | 7.93 % | 6.56 % | 10.0 |
| Industry Average | 1,966.26 Cr | 314.97 | 38.84 | 189.00 | 0.34% | 12.76% | 24.70% | 7.38 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,483 | 3,380 | 3,258 | 3,369 | 3,309 | 3,426 | 3,654 | 3,833 | 3,735 | 3,814 | 3,901 | 3,832 | 3,612 |
| Expenses | 3,219 | 3,011 | 2,975 | 2,984 | 2,978 | 3,060 | 3,245 | 3,441 | 3,281 | 3,404 | 3,447 | 3,446 | 3,176 |
| Operating Profit | 264 | 370 | 284 | 386 | 332 | 366 | 408 | 392 | 454 | 410 | 454 | 386 | 436 |
| OPM % | 8% | 11% | 9% | 11% | 10% | 11% | 11% | 10% | 12% | 11% | 12% | 10% | 12% |
| Other Income | -70 | -52 | -362 | 20 | -64 | -319 | -149 | -73 | 65 | 132 | 21 | 29 | 8 |
| Interest | 133 | 130 | 135 | 132 | 140 | 128 | 162 | 178 | 174 | 184 | 199 | 188 | 193 |
| Depreciation | 144 | 166 | 160 | 164 | 166 | 165 | 173 | 173 | 172 | 176 | 187 | 189 | 202 |
| Profit before tax | -83 | 22 | -373 | 110 | -39 | -247 | -76 | -31 | 173 | 182 | 89 | 38 | 49 |
| Tax % | 3% | 96% | 12% | 42% | 72% | 10% | 30% | 108% | 21% | 7% | 35% | 29% | 26% |
| Net Profit | -85 | 1 | -416 | 63 | -67 | -271 | -98 | -65 | 137 | 169 | 58 | 27 | 36 |
| EPS in Rs | -11.83 | 0.12 | -57.63 | 8.77 | -9.31 | -37.51 | -13.63 | -8.95 | 18.95 | 23.34 | 8.03 | 3.73 | 5.01 |
Last Updated: March 3, 2026, 2:04 pm
Below is a detailed analysis of the quarterly data for Uflex Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 3,612.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,832.00 Cr. (Sep 2025) to 3,612.00 Cr., marking a decrease of 220.00 Cr..
- For Expenses, as of Dec 2025, the value is 3,176.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3,446.00 Cr. (Sep 2025) to 3,176.00 Cr., marking a decrease of 270.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 436.00 Cr.. The value appears strong and on an upward trend. It has increased from 386.00 Cr. (Sep 2025) to 436.00 Cr., marking an increase of 50.00 Cr..
- For OPM %, as of Dec 2025, the value is 12.00%. The value appears strong and on an upward trend. It has increased from 10.00% (Sep 2025) to 12.00%, marking an increase of 2.00%.
- For Other Income, as of Dec 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29.00 Cr. (Sep 2025) to 8.00 Cr., marking a decrease of 21.00 Cr..
- For Interest, as of Dec 2025, the value is 193.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 188.00 Cr. (Sep 2025) to 193.00 Cr., marking an increase of 5.00 Cr..
- For Depreciation, as of Dec 2025, the value is 202.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 189.00 Cr. (Sep 2025) to 202.00 Cr., marking an increase of 13.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 49.00 Cr.. The value appears strong and on an upward trend. It has increased from 38.00 Cr. (Sep 2025) to 49.00 Cr., marking an increase of 11.00 Cr..
- For Tax %, as of Dec 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Sep 2025) to 26.00%, marking a decrease of 3.00%.
- For Net Profit, as of Dec 2025, the value is 36.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Sep 2025) to 36.00 Cr., marking an increase of 9.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 5.01. The value appears strong and on an upward trend. It has increased from 3.73 (Sep 2025) to 5.01, marking an increase of 1.28.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: February 26, 2026, 6:46 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,826 | 6,130 | 6,366 | 6,505 | 6,802 | 7,957 | 7,405 | 8,889 | 13,127 | 14,663 | 13,364 | 15,036 | 15,159 |
| Expenses | 5,137 | 5,395 | 5,561 | 5,630 | 5,921 | 6,969 | 6,324 | 7,085 | 10,956 | 12,913 | 11,976 | 13,344 | 13,473 |
| Operating Profit | 688 | 735 | 805 | 874 | 881 | 988 | 1,081 | 1,804 | 2,171 | 1,749 | 1,387 | 1,692 | 1,686 |
| OPM % | 12% | 12% | 13% | 13% | 13% | 12% | 15% | 20% | 17% | 12% | 10% | 11% | 11% |
| Other Income | 29 | 18 | 38 | 25 | 22 | 19 | 28 | 23 | 71 | -21 | -745 | -51 | 191 |
| Interest | 233 | 187 | 176 | 187 | 197 | 218 | 225 | 229 | 322 | 473 | 536 | 698 | 764 |
| Depreciation | 267 | 279 | 286 | 318 | 352 | 381 | 403 | 456 | 537 | 599 | 655 | 695 | 755 |
| Profit before tax | 217 | 286 | 382 | 395 | 354 | 409 | 481 | 1,142 | 1,382 | 656 | -549 | 248 | 358 |
| Tax % | 7% | 11% | 17% | 11% | 12% | 23% | 23% | 26% | 20% | 27% | 26% | 43% | |
| Net Profit | 202 | 256 | 317 | 351 | 312 | 315 | 371 | 844 | 1,099 | 481 | -691 | 142 | 289 |
| EPS in Rs | 27.92 | 35.28 | 43.46 | 48.26 | 43.00 | 43.46 | 51.21 | 116.73 | 152.09 | 66.57 | -95.69 | 19.71 | 40.11 |
| Dividend Payout % | 9% | 8% | 7% | 7% | 5% | 5% | 4% | 2% | 2% | 5% | -1% | 15% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 26.73% | 23.83% | 10.73% | -11.11% | 0.96% | 17.78% | 127.49% | 30.21% | -56.23% | -243.66% | 120.55% |
| Change in YoY Net Profit Growth (%) | 0.00% | -2.90% | -13.10% | -21.84% | 12.07% | 16.82% | 109.72% | -97.28% | -86.45% | -187.43% | 364.21% |
Uflex Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 15% |
| 3 Years: | 5% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -8% |
| 3 Years: | -40% |
| TTM: | 28% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 11% |
| 3 Years: | -11% |
| 1 Year: | -31% |
| Return on Equity | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| Last Year: | 3% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 4, 2025, 2:09 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 | 72 |
| Reserves | 2,751 | 2,935 | 3,376 | 3,572 | 3,907 | 4,232 | 4,625 | 5,484 | 6,624 | 7,433 | 7,153 | 7,324 | 7,655 |
| Borrowings | 2,416 | 2,210 | 2,139 | 2,102 | 2,079 | 2,105 | 3,626 | 4,041 | 4,787 | 5,704 | 6,947 | 8,353 | 9,326 |
| Other Liabilities | 1,356 | 1,250 | 1,217 | 1,402 | 1,629 | 1,550 | 1,693 | 2,222 | 2,959 | 3,229 | 3,176 | 3,687 | 3,725 |
| Total Liabilities | 6,595 | 6,468 | 6,804 | 7,148 | 7,688 | 7,960 | 10,016 | 11,820 | 14,441 | 16,438 | 17,348 | 19,437 | 20,779 |
| Fixed Assets | 3,378 | 3,240 | 3,255 | 3,394 | 3,766 | 3,759 | 3,808 | 5,032 | 6,417 | 7,786 | 8,223 | 8,739 | 9,009 |
| CWIP | 74 | 32 | 229 | 498 | 196 | 261 | 2,007 | 1,518 | 671 | 466 | 538 | 725 | 1,320 |
| Investments | 126 | 138 | 111 | 76 | 85 | 42 | 199 | 205 | 212 | 191 | 170 | 145 | 131 |
| Other Assets | 3,017 | 3,058 | 3,210 | 3,180 | 3,641 | 3,898 | 4,003 | 5,065 | 7,141 | 7,994 | 8,416 | 9,828 | 10,319 |
| Total Assets | 6,595 | 6,468 | 6,804 | 7,148 | 7,688 | 7,960 | 10,016 | 11,820 | 14,441 | 16,438 | 17,348 | 19,437 | 20,779 |
Below is a detailed analysis of the balance sheet data for Uflex Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 72.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 72.00 Cr..
- For Reserves, as of Sep 2025, the value is 7,655.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,324.00 Cr. (Mar 2025) to 7,655.00 Cr., marking an increase of 331.00 Cr..
- For Borrowings, as of Sep 2025, the value is 9,326.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 8,353.00 Cr. (Mar 2025) to 9,326.00 Cr., marking an increase of 973.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 3,725.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,687.00 Cr. (Mar 2025) to 3,725.00 Cr., marking an increase of 38.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 20,779.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 19,437.00 Cr. (Mar 2025) to 20,779.00 Cr., marking an increase of 1,342.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 9,009.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,739.00 Cr. (Mar 2025) to 9,009.00 Cr., marking an increase of 270.00 Cr..
- For CWIP, as of Sep 2025, the value is 1,320.00 Cr.. The value appears strong and on an upward trend. It has increased from 725.00 Cr. (Mar 2025) to 1,320.00 Cr., marking an increase of 595.00 Cr..
- For Investments, as of Sep 2025, the value is 131.00 Cr.. The value appears to be declining and may need further review. It has decreased from 145.00 Cr. (Mar 2025) to 131.00 Cr., marking a decrease of 14.00 Cr..
- For Other Assets, as of Sep 2025, the value is 10,319.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,828.00 Cr. (Mar 2025) to 10,319.00 Cr., marking an increase of 491.00 Cr..
- For Total Assets, as of Sep 2025, the value is 20,779.00 Cr.. The value appears strong and on an upward trend. It has increased from 19,437.00 Cr. (Mar 2025) to 20,779.00 Cr., marking an increase of 1,342.00 Cr..
However, the Borrowings (9,326.00 Cr.) are higher than the Reserves (7,655.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 686.00 | 733.00 | 803.00 | 872.00 | 879.00 | 986.00 | -2.00 | -3.00 | -2.00 | -4.00 | -5.00 | -7.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 94 | 90 | 85 | 93 | 104 | 94 | 96 | 99 | 98 | 80 | 94 | 91 |
| Inventory Days | 60 | 63 | 64 | 70 | 72 | 63 | 73 | 89 | 86 | 91 | 84 | 100 |
| Days Payable | 86 | 72 | 80 | 98 | 108 | 79 | 90 | 104 | 92 | 85 | 90 | 90 |
| Cash Conversion Cycle | 69 | 80 | 68 | 64 | 68 | 78 | 79 | 83 | 92 | 87 | 88 | 101 |
| Working Capital Days | 22 | 23 | 23 | 22 | 36 | 32 | 31 | 45 | 56 | 41 | 36 | 20 |
| ROCE % | 9% | 9% | 10% | 10% | 9% | 10% | 10% | 15% | 17% | 10% | 6% | 8% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Motilal Oswal Nifty Microcap 250 Index Fund | 40,093 | 0.18 | 2.4 | 40,093 | 2025-04-22 15:56:52 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 19.71 | -95.69 | 66.57 | 152.09 | 116.73 |
| Diluted EPS (Rs.) | 19.71 | -95.69 | 66.57 | 152.09 | 116.73 |
| Cash EPS (Rs.) | 118.09 | -3.17 | 150.56 | 226.63 | 179.94 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1023.00 | 1000.53 | 1039.38 | 927.25 | 769.49 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1023.00 | 1000.53 | 1039.38 | 927.25 | 769.49 |
| Revenue From Operations / Share (Rs.) | 2082.23 | 1850.62 | 2030.49 | 1817.87 | 1231.21 |
| PBDIT / Share (Rs.) | 254.02 | 211.36 | 261.17 | 315.74 | 253.01 |
| PBIT / Share (Rs.) | 157.79 | 120.59 | 178.22 | 241.35 | 189.90 |
| PBT / Share (Rs.) | 36.51 | -74.24 | 91.88 | 191.42 | 158.17 |
| Net Profit / Share (Rs.) | 21.86 | -93.94 | 67.61 | 152.25 | 116.83 |
| NP After MI And SOA / Share (Rs.) | 19.71 | -95.69 | 66.57 | 152.09 | 116.73 |
| PBDIT Margin (%) | 12.19 | 11.42 | 12.86 | 17.36 | 20.54 |
| PBIT Margin (%) | 7.57 | 6.51 | 8.77 | 13.27 | 15.42 |
| PBT Margin (%) | 1.75 | -4.01 | 4.52 | 10.53 | 12.84 |
| Net Profit Margin (%) | 1.04 | -5.07 | 3.32 | 8.37 | 9.48 |
| NP After MI And SOA Margin (%) | 0.94 | -5.17 | 3.27 | 8.36 | 9.48 |
| Return on Networth / Equity (%) | 1.92 | -9.57 | 6.41 | 16.42 | 15.16 |
| Return on Capital Employeed (%) | 8.78 | 7.20 | 11.10 | 16.81 | 15.67 |
| Return On Assets (%) | 0.73 | -3.98 | 2.92 | 7.60 | 7.12 |
| Long Term Debt / Equity (X) | 0.65 | 0.57 | 0.46 | 0.45 | 0.50 |
| Total Debt / Equity (X) | 1.10 | 0.93 | 0.73 | 0.68 | 0.64 |
| Asset Turnover Ratio (%) | 0.81 | 0.79 | 0.63 | 0.64 | 0.62 |
| Current Ratio (X) | 1.31 | 1.46 | 1.56 | 1.64 | 1.55 |
| Quick Ratio (X) | 0.91 | 1.09 | 1.08 | 1.19 | 1.18 |
| Inventory Turnover Ratio (X) | 6.75 | 3.88 | 3.36 | 4.03 | 3.85 |
| Dividend Payout Ratio (NP) (%) | 5.07 | -3.13 | 4.50 | 1.64 | 1.71 |
| Dividend Payout Ratio (CP) (%) | 0.86 | -60.99 | 2.00 | 1.10 | 1.11 |
| Earning Retention Ratio (%) | 94.93 | 103.13 | 95.50 | 98.36 | 98.29 |
| Cash Earning Retention Ratio (%) | 99.14 | 160.99 | 98.00 | 98.90 | 98.89 |
| Interest Coverage Ratio (X) | 2.63 | 2.85 | 3.98 | 7.07 | 7.98 |
| Interest Coverage Ratio (Post Tax) (X) | 1.48 | 1.36 | 2.35 | 4.53 | 4.68 |
| Enterprise Value (Cr.) | 10561.28 | 8579.76 | 6834.46 | 8380.47 | 5629.29 |
| EV / Net Operating Revenue (X) | 0.70 | 0.64 | 0.46 | 0.63 | 0.63 |
| EV / EBITDA (X) | 5.76 | 5.62 | 3.62 | 3.68 | 3.08 |
| MarketCap / Net Operating Revenue (X) | 0.23 | 0.21 | 0.16 | 0.33 | 0.30 |
| Retention Ratios (%) | 94.92 | 103.13 | 95.49 | 98.35 | 98.28 |
| Price / BV (X) | 0.48 | 0.40 | 0.32 | 0.65 | 0.49 |
| Price / Net Operating Revenue (X) | 0.23 | 0.21 | 0.16 | 0.33 | 0.30 |
| EarningsYield | 0.03 | -0.23 | 0.19 | 0.24 | 0.30 |
After reviewing the key financial ratios for Uflex Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -95.69 (Mar 24) to 19.71, marking an increase of 115.40.
- For Diluted EPS (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -95.69 (Mar 24) to 19.71, marking an increase of 115.40.
- For Cash EPS (Rs.), as of Mar 25, the value is 118.09. This value is within the healthy range. It has increased from -3.17 (Mar 24) to 118.09, marking an increase of 121.26.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,023.00. It has increased from 1,000.53 (Mar 24) to 1,023.00, marking an increase of 22.47.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1,023.00. It has increased from 1,000.53 (Mar 24) to 1,023.00, marking an increase of 22.47.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,082.23. It has increased from 1,850.62 (Mar 24) to 2,082.23, marking an increase of 231.61.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 254.02. This value is within the healthy range. It has increased from 211.36 (Mar 24) to 254.02, marking an increase of 42.66.
- For PBIT / Share (Rs.), as of Mar 25, the value is 157.79. This value is within the healthy range. It has increased from 120.59 (Mar 24) to 157.79, marking an increase of 37.20.
- For PBT / Share (Rs.), as of Mar 25, the value is 36.51. This value is within the healthy range. It has increased from -74.24 (Mar 24) to 36.51, marking an increase of 110.75.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 21.86. This value is within the healthy range. It has increased from -93.94 (Mar 24) to 21.86, marking an increase of 115.80.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 19.71. This value is within the healthy range. It has increased from -95.69 (Mar 24) to 19.71, marking an increase of 115.40.
- For PBDIT Margin (%), as of Mar 25, the value is 12.19. This value is within the healthy range. It has increased from 11.42 (Mar 24) to 12.19, marking an increase of 0.77.
- For PBIT Margin (%), as of Mar 25, the value is 7.57. This value is below the healthy minimum of 10. It has increased from 6.51 (Mar 24) to 7.57, marking an increase of 1.06.
- For PBT Margin (%), as of Mar 25, the value is 1.75. This value is below the healthy minimum of 10. It has increased from -4.01 (Mar 24) to 1.75, marking an increase of 5.76.
- For Net Profit Margin (%), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 5. It has increased from -5.07 (Mar 24) to 1.04, marking an increase of 6.11.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 8. It has increased from -5.17 (Mar 24) to 0.94, marking an increase of 6.11.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.92. This value is below the healthy minimum of 15. It has increased from -9.57 (Mar 24) to 1.92, marking an increase of 11.49.
- For Return on Capital Employeed (%), as of Mar 25, the value is 8.78. This value is below the healthy minimum of 10. It has increased from 7.20 (Mar 24) to 8.78, marking an increase of 1.58.
- For Return On Assets (%), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 5. It has increased from -3.98 (Mar 24) to 0.73, marking an increase of 4.71.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.65. This value is within the healthy range. It has increased from 0.57 (Mar 24) to 0.65, marking an increase of 0.08.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.10. This value exceeds the healthy maximum of 1. It has increased from 0.93 (Mar 24) to 1.10, marking an increase of 0.17.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.81. It has increased from 0.79 (Mar 24) to 0.81, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 1.5. It has decreased from 1.46 (Mar 24) to 1.31, marking a decrease of 0.15.
- For Quick Ratio (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has decreased from 1.09 (Mar 24) to 0.91, marking a decrease of 0.18.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.75. This value is within the healthy range. It has increased from 3.88 (Mar 24) to 6.75, marking an increase of 2.87.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 5.07. This value is below the healthy minimum of 20. It has increased from -3.13 (Mar 24) to 5.07, marking an increase of 8.20.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 20. It has increased from -60.99 (Mar 24) to 0.86, marking an increase of 61.85.
- For Earning Retention Ratio (%), as of Mar 25, the value is 94.93. This value exceeds the healthy maximum of 70. It has decreased from 103.13 (Mar 24) to 94.93, marking a decrease of 8.20.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 99.14. This value exceeds the healthy maximum of 70. It has decreased from 160.99 (Mar 24) to 99.14, marking a decrease of 61.85.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.63. This value is below the healthy minimum of 3. It has decreased from 2.85 (Mar 24) to 2.63, marking a decrease of 0.22.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 3. It has increased from 1.36 (Mar 24) to 1.48, marking an increase of 0.12.
- For Enterprise Value (Cr.), as of Mar 25, the value is 10,561.28. It has increased from 8,579.76 (Mar 24) to 10,561.28, marking an increase of 1,981.52.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 1. It has increased from 0.64 (Mar 24) to 0.70, marking an increase of 0.06.
- For EV / EBITDA (X), as of Mar 25, the value is 5.76. This value is within the healthy range. It has increased from 5.62 (Mar 24) to 5.76, marking an increase of 0.14.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 24) to 0.23, marking an increase of 0.02.
- For Retention Ratios (%), as of Mar 25, the value is 94.92. This value exceeds the healthy maximum of 70. It has decreased from 103.13 (Mar 24) to 94.92, marking a decrease of 8.21.
- For Price / BV (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has increased from 0.40 (Mar 24) to 0.48, marking an increase of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 1. It has increased from 0.21 (Mar 24) to 0.23, marking an increase of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from -0.23 (Mar 24) to 0.03, marking an increase of 0.26.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Uflex Ltd:
- Net Profit Margin: 1.04%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 8.78% (Industry Average ROCE: 12.76%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.92% (Industry Average ROE: 24.7%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.48
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.91
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 13.8 (Industry average Stock P/E: 38.84)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.1
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.04%
About the Company - Qualitative Analysis
Uflex Ltd. is a Public Limited Listed company incorporated on 21/06/1988 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1988PLC032166 and registration number is 032166. Currently Company is involved in the business activities of Manufacture of other plastics products. Company's Total Operating Revenue is Rs. 7724.74 Cr. and Equity Capital is Rs. 72.21 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Packaging & Containers | 305, Third Floor, Bhanot Corner, New Delhi Delhi 110048 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ashok Chaturvedi | Chairman & Managing Director |
| Mr. Jeevaraj Gopal Pillai | Whole Time Director |
| Mrs. Sujit Kumar Varma | Independent Director |
| Mr. Ghyanendra Nath Bajpai | Independent Director |
| Mrs. Rashmi Verma | Independent Director |
| Mr. Paresh Nath Sharma | Independent Director |
FAQ
What is the intrinsic value of Uflex Ltd?
Uflex Ltd's intrinsic value (as of 11 March 2026) is ₹299.67 which is 34.28% lower the current market price of ₹456.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,291 Cr. market cap, FY2025-2026 high/low of ₹686/447, reserves of ₹7,655 Cr, and liabilities of ₹20,779 Cr.
What is the Market Cap of Uflex Ltd?
The Market Cap of Uflex Ltd is 3,291 Cr..
What is the current Stock Price of Uflex Ltd as on 11 March 2026?
The current stock price of Uflex Ltd as on 11 March 2026 is ₹456.
What is the High / Low of Uflex Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Uflex Ltd stocks is ₹686/447.
What is the Stock P/E of Uflex Ltd?
The Stock P/E of Uflex Ltd is 13.8.
What is the Book Value of Uflex Ltd?
The Book Value of Uflex Ltd is 1,070.
What is the Dividend Yield of Uflex Ltd?
The Dividend Yield of Uflex Ltd is 0.66 %.
What is the ROCE of Uflex Ltd?
The ROCE of Uflex Ltd is 7.75 %.
What is the ROE of Uflex Ltd?
The ROE of Uflex Ltd is 3.29 %.
What is the Face Value of Uflex Ltd?
The Face Value of Uflex Ltd is 10.0.